Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Kane Biotech Announces Second Closing of Private Placement Offering

Marketwired December 17, 2014

Curemark CEO Delivers Keynote Speech at Epigenetics Conference

PR Newswire December 17, 2014

Breath Analyzers Market Worth $1,539.1 Million by 2019

PR Newswire December 17, 2014

BIONOVA asks: Men Skincare is a necessity or a treat?

PR Newswire December 17, 2014

Provectus Biopharmaceuticals to Sponsor American Association of Physicians of Indian Origin

Business Wire December 17, 2014

BioShares Launches Two New Biotechnology ETFs (Nasdaq: BBC, BBP)

GlobeNewswire December 17, 2014

Flexus Biosciences, a Cancer Immunotherapy Company Focused on Agents for the Reversal of Tumor Immunosuppression (ARTIS), Announces $38M Financing

GlobeNewswire December 17, 2014

Paytronix Works With NCR to Bring Loyalty Programs to Restaurants

Marketwired December 17, 2014

Generex Announces Participation in MedCannAccess® - CannScience Partnership on Non-Smoked Forms of Marijuana

Canada NewsWire December 17, 2014

LabCorp Named Laboratory Service Provider of the Pro Football Legends

Business Wire December 17, 2014

Seven Books That Will Convince You to Read Self-Published Authors

PR Newswire December 17, 2014

Amid Ongoing Global Water Shortages, Desalitech Responds With Water Efficiency Guarantee

GlobeNewswire December 17, 2014

TG Therapeutics, Inc. Announces Appointment of Kenneth Hoberman to Board of Directors

GlobeNewswire December 17, 2014

Biocept's Patented Platform Identifies Clinically HER2-Negative Patients With HER2-Positive Circulating Tumor Cells

GlobeNewswire December 17, 2014

Nasdaq Lists BioShares(TM) Biotechnology Clinical Trials Fund and BioShares(TM) Biotechnology Products Fund

GlobeNewswire December 17, 2014

Nasdaq Lists BioShares(TM) Biotechnology Clinical Trials Fund and BioShares(TM) Biotechnology Products Fund

Thomson Reuters ONE December 17, 2014

Cerulean Announces First Patient Dosed with CRLX301 in Phase 1/2a Trial in Advanced Solid Tumors

Business Wire December 17, 2014

X-Chem Licenses Cardiovascular Drug Discovery Program to Bayer Pharma AG

Business Wire December 17, 2014

BioBlast Receives Notice of Patent Issuance From USPTO for Its Novel Fusion Protein-Based Platform for the Treatment of Friedrich's Ataxia

GlobeNewswire December 17, 2014

Relypsa to be Added to NASDAQ Biotechnology Index

GlobeNewswire December 17, 2014